Key result
The molecular mechanisms of Takotsubo syndrome involve catecholaminergic myocardial stunning, microvascular dysfunction, increased inflammation, and changes in cardiomyocyte metabolism.
Why the study?
The pathophysiology of Takotsubo syndrome is not completely understood and there is a paucity of evidence to guide treatment.
This review summarizes the molecular mechanisms underlying Takotsubo syndrome, highlighting catecholaminergic stunning, microvascular dysfunction, inflammation, and metabolic changes.
TTS mechanisms remain incompletely defined; leaves open critical questions for targeted mechanistic studies.
Takotsubo syndrome (TTS) is a severe but reversible acute heart failure syndrome that occurs following high catecholaminergic stress. TTS patients are similar to those with acute coronary syndrome, with chest pain, dyspnoea and ST segment changes on electrocardiogram, but are characterised by apical akinesia of the left ventricle, with basal hyperkinesia in the absence of culprit coronary artery stenosis. The pathophysiology of TTS is not completely understood and there is a paucity of evidence to guide treatment. The mechanisms of TTS are thought to involve catecholaminergic myocardial stunning, microvascular dysfunction, increased inflammation and changes in cardiomyocyte metabolism. Here, we summarise the available literature to focus on the molecular basis for the pathophysiology of TTS to advance the understanding of the condition.
No takes yet. Share an insight, caveat, or question.
Couch et al. (2022) conducted a review in Takotsubo syndrome. The molecular mechanisms of Takotsubo syndrome involve catecholaminergic myocardial stunning, microvascular dysfunction, increased inflammation, and changes in cardiomyocyte metabolism.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: